Salvage Therapy after Allogeneic Hematopoietic Cell Transplantation: Targeted and Low-Intensity Treatment Options in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Patients with high-risk myeloid neoplasms, including myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), are offered allogeneic hematopoietic cell transplantation (alloHCT) to improve the likelihood of long-term disease control. More than 50% of patients with high-risk disease will rela...

Descripción completa

Detalles Bibliográficos
Autores principales: Culos, Katie, Byrne, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Atlantis Press 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432395/
https://www.ncbi.nlm.nih.gov/pubmed/34595416
http://dx.doi.org/10.2991/chi.d.190503.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432395/
https://www.ncbi.nlm.nih.gov/pubmed/34595416
http://dx.doi.org/10.2991/chi.d.190503.001

Ejemplares similares